Blood markers and score to predict death in sepsis patients
Part of Immune system & allergy clinical trials.
This study looks at blood markers and a clinical score to help predict the risk of death in people with sepsis in the ICU. It may help doctors identify who needs more aggressive treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be in the ICU with a diagnosis of sepsis (a severe infection response).
- You must not have a blood cancer or be getting chemotherapy.
- You must not be on long-term immune-suppressing drugs (e.g., after transplant or high-dose steroids).
- You must not be pregnant or breastfeeding.
- Your ICU stay must be longer than 24 hours.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks if certain blood markers (CRP, CRP/albumin ratio, and neutrophil/lymphocyte ratio) can predict how well sepsis patients with normal blood pressure will do. It aims to help doctors better manage infections and survival.
This study compares two blood test methods to help predict sepsis (a severe infection) and patient outcomes in the intensive care unit. It may help doctors identify high-risk patients faster and more accurately.
This study looks at simple blood tests (like levels of certain white blood cells and a protein called procalcitonin) to see if they can predict how well people with sepsis will do in the intensive care unit. It may help doctors understand your infection better.
This trial looks at patterns in certain immune cells (neutrophils) in people with sepsis in the ICU, including those who have a breathing tube. It may help doctors better understand how the immune system changes during sepsis and could guide future care.
This research study measures special blood markers (microRNAs) in patients with septic shock or critical illness to understand how the body responds to severe infection. Results may help doctors better diagnose and treat sepsis in the future.
This study checks if a simple blood flow measurement can help predict which patients with sepsis are at higher risk of dying within 28 days. The goal is to see if this test can guide treatment decisions in the ICU.
Hear when a new Inflamatory Markers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.